 | Up a level |
Orrell, C, Kintu, K, Coombs, JA, Amara, A, Myer, L, Kaboggoza, J 
ORCID: 0000-0001-9510-0474, Simmons, B, Else, L, Heiberg, C, Waitt, C et al (show 5 more authors)
(2018)
DolPHIN-1: Randomised controlled trial of dolutegravir (DTG)- versus efavirenz (EFV)-based therapy in mothers initiating antiretroviral treatment in late pregnancy.
.
Jones, S, Kay, K, Hodel, EM ORCID: 0000-0001-5821-1685, Chy, S, Mbituyumuremyi, A, Uwimana, A, Menard, D, Felger, I and Hastings, I
(2019)
Improving methods for analysing anti-malarial drug efficacy trials: molecular correction based on length-polymorphic markers msp-1, msp-2 and glurp.
Antimicrobial agents and chemotherapy, 63 (9).
e00590-e00519.